{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:46Z","timestamp":1793707966561,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Evaluate the role of platelet-rich fibrin (PRF) as a natural carrier for antibiotics delivery through the analysis of drug release and antimicrobial activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      PRF was prepared according to the L-PRF (\n                      <jats:italic>leukocyte- and platelet-rich fibrin<\/jats:italic>\n                      ) protocol. One tube was used as control (without drug), while an increasing amount of gentamicin (0.25\u00a0mg, G1; 0.5\u00a0mg, G2; 0.75\u00a0mg, G3; 1\u00a0mg, G4), linezolid (0.5\u00a0mg, L1; 1\u00a0mg, L2; 1.5\u00a0mg, L3; 2\u00a0mg, L4), vancomycin (1.25\u00a0mg, V1; 2.5\u00a0mg, V2; 3.75\u00a0mg, V3; 5\u00a0mg, V4) was added to the other tubes. At different times the supernatant was collected and analyzed. Strains of\n                      <jats:italic>E. coli, P. aeruginosa, S. mitis, H. influenzae, S. pneumoniae, S. aureus<\/jats:italic>\n                      were used to assess the antimicrobial effect of PRF membranes prepared with the same antibiotics and compared to control PRF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Vancomycin interfered with PRF formation. Gentamicin and linezolid did not change the physical properties of PRF and were released from membranes in the time intervals examined. The inhibition area analysis showed that control PRF had slight antibacterial activity against all tested microorganisms. Gentamicin-PRF had a massive antibacterial activity against all tested microorganisms. Results were similar for linezolid-PRF, except for its antibacterial activity against\n                      <jats:italic>E. coli<\/jats:italic>\n                      and\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      that was comparable to control PRF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PRF loaded with antibiotics allowed the release of antimicrobial drugs in an effective concentration. Using PRF loaded with antibiotics after oral surgery may reduce the risk of post-operative infection, replace or enhance systemic antibiotic therapy while preserving the healing properties of PRF. Further studies are needed to prove that PRF loaded with antibiotics represents a topical antibiotic delivery tool for oral surgical procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-023-02814-5","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:02:38Z","timestamp":1678320158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-2681","authenticated-orcid":false,"given":"Francesco","family":"Bennardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-7902","authenticated-orcid":false,"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Palleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-5018","authenticated-orcid":false,"given":"Leonzio","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-6579","authenticated-orcid":false,"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-6979","authenticated-orcid":false,"given":"Amerigo","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"2814_CR1","unstructured":"World Health Organization (2020) Antimicrobial resistance. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed 18 Apr 2021"},{"key":"2814_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/14787210.2020.1796638","volume":"18","author":"MAA Majumder","year":"2020","unstructured":"Majumder MAA, Singh K, Hilaire MG-S, et al. Tackling antimicrobial resistance by promoting antimicrobial stewardship in medical and allied health professional curricula. Expert Rev Anti Infect Ther. 2020;18:1245\u201358. https:\/\/doi.org\/10.1080\/14787210.2020.1796638.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2814_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/cid\/ciz1118","volume":"71","author":"DA Goff","year":"2020","unstructured":"Goff DA, Mangino JE, Glassman AH, et al. Review of guidelines for dental antibiotic prophylaxis for prevention of endocarditis and prosthetic joint infections and need for dental stewardship. Clin Infect Dis. 2020;71:455\u201362. https:\/\/doi.org\/10.1093\/cid\/ciz1118.","journal-title":"Clin Infect Dis"},{"key":"2814_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tibtech.2019.10.008","volume":"38","author":"SA Kelly","year":"2020","unstructured":"Kelly SA, Rodgers AM, O\u2019Brien SC, et al. Gut check time: antibiotic delivery strategies to reduce antimicrobial resistance. Trends Biotechnol. 2020;38:447\u201362. https:\/\/doi.org\/10.1016\/j.tibtech.2019.10.008.","journal-title":"Trends Biotechnol"},{"key":"2814_CR5","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/S0142-9612(03)00340-5","volume":"24","author":"JL Drury","year":"2003","unstructured":"Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24:4337\u201351. https:\/\/doi.org\/10.1016\/S0142-9612(03)00340-5.","journal-title":"Biomaterials"},{"key":"2814_CR6","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.msec.2009.07.014","volume":"29","author":"SK Nandi","year":"2009","unstructured":"Nandi SK, Mukherjee P, Roy S, et al. Local antibiotic delivery systems for the treatment of osteomyelitis\u2014a review. Mater Sci Eng C. 2009;29:2478\u201385. https:\/\/doi.org\/10.1016\/j.msec.2009.07.014.","journal-title":"Mater Sci Eng C"},{"key":"2814_CR7","doi-asserted-by":"publisher","first-page":"41808","DOI":"10.1038\/srep41808","volume":"7","author":"Q Wang","year":"2017","unstructured":"Wang Q, Chen C, Liu W, et al. Levofloxacin loaded mesoporous silica microspheres\/nano-hydroxyapatite\/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects. Sci Rep. 2017;7:41808. https:\/\/doi.org\/10.1038\/srep41808.","journal-title":"Sci Rep"},{"key":"2814_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2008.05.020","volume":"130","author":"M Zilberman","year":"2008","unstructured":"Zilberman M, Elsner J. Antibiotic-eluting medical devices for various applications. J Control Release. 2008;130:202\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2008.05.020.","journal-title":"J Control Release"},{"key":"2814_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.copbio.2018.11.010","volume":"58","author":"Y Lu","year":"2019","unstructured":"Lu Y, Hu Q, Jiang C, Gu Z. Platelet for drug delivery. Curr Opin Biotechnol. 2019;58:81\u201391. https:\/\/doi.org\/10.1016\/j.copbio.2018.11.010.","journal-title":"Curr Opin Biotechnol"},{"key":"2814_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jconrel.2010.06.025","volume":"148","author":"PP Spicer","year":"2010","unstructured":"Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. J Control Release. 2010;148:49\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2010.06.025.","journal-title":"J Control Release"},{"key":"2814_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1248\/bpb.23.371","volume":"23","author":"H Yoshida","year":"2000","unstructured":"Yoshida H, Yamaoka Y, Shinoyama M, Kamiya A. Novel drug delivery system using autologous fibrin glue. release properties of anti-cancer drugs. Biol Pharm Bull. 2000;23:371\u20134. https:\/\/doi.org\/10.1248\/bpb.23.371.","journal-title":"Biol Pharm Bull"},{"key":"2814_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/ten.teb.2016.0233","volume":"23","author":"RJ Miron","year":"2017","unstructured":"Miron RJ, Fujioka-Kobayashi M, Bishara M, et al. Platelet-rich fibrin and soft tissue wound healing: a systematic review. Tissue Eng B Rev. 2017;23:83\u201399. https:\/\/doi.org\/10.1089\/ten.teb.2016.0233.","journal-title":"Tissue Eng B Rev"},{"key":"2814_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-020-03702-w","author":"F Bennardo","year":"2021","unstructured":"Bennardo F, Liborio F, Barone S, et al. Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study. Clin Oral Investig. 2021. https:\/\/doi.org\/10.1007\/s00784-020-03702-w.","journal-title":"Clin Oral Investig"},{"key":"2814_CR14","doi-asserted-by":"publisher","first-page":"100838","DOI":"10.1016\/j.ajoc.2020.100838","volume":"20","author":"M Rechichi","year":"2020","unstructured":"Rechichi M, Ferrise M, Romano F, et al. Autologous platelet-rich plasma in the treatment of refractory corneal ulcers: a case report. Am J Ophthalmol Case Rep. 2020;20:100838. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100838.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2814_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/iwj.12500","volume":"13","author":"F Romano","year":"2016","unstructured":"Romano F, Paolino FM, Rizzo BA, et al. The use of growth factors, CD34 + cells and fibrin for the management of chronic venous ulcers. Int Wound J. 2016;13:1011\u20133. https:\/\/doi.org\/10.1111\/iwj.12500.","journal-title":"Int Wound J"},{"key":"2814_CR16","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.3390\/ijms222111553","volume":"22","author":"K Egle","year":"2021","unstructured":"Egle K, Salma I, Dubnika A. From blood to regenerative tissue: how autologous platelet-rich fibrin can be combined with other materials to ensure controlled drug and growth factor release. Int J Mol Sci. 2021;22:11553. https:\/\/doi.org\/10.3390\/ijms222111553.","journal-title":"Int J Mol Sci"},{"key":"2814_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","volume":"27","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158\u201367. https:\/\/doi.org\/10.1016\/j.tibtech.2008.11.009.","journal-title":"Trends Biotechnol"},{"key":"2814_CR18","first-page":"55","volume":"42","author":"J Choukroun","year":"2001","unstructured":"Choukroun J, Adda F, Schoeffler C, Vervelle A. Une opportunite en paro-implantologie: Le PRF. Implantodontie. 2001;42:55\u201362.","journal-title":"Implantodontie"},{"key":"2814_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1302\/0301-620X.89B3.18491","volume":"89B","author":"TM Bielecki","year":"2007","unstructured":"Bielecki TM, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances. J Bone Joint Surg Br. 2007;89B:417\u201320. https:\/\/doi.org\/10.1302\/0301-620X.89B3.18491.","journal-title":"J Bone Joint Surg Br"},{"key":"2814_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2106\/JBJS.H.01061","volume":"91","author":"T Bielecki","year":"2009","unstructured":"Bielecki T, Gazdzik TS. Antimicrobial activity of platelet-rich gel after antibiotic administration\u2014a preliminary report. Orthop Proc Br Editor Soc Bone Jt Surg. 2009;91:131.","journal-title":"Orthop Proc Br Editor Soc Bone Jt Surg"},{"key":"2814_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/jcpe.13063","volume":"46","author":"D Polak","year":"2019","unstructured":"Polak D, Clemer-Shamai N, Shapira L. Incorporating antibiotics into platelet-rich fibrin: a novel antibiotics slow-release biological device. J Clin Periodontol. 2019;46:241\u20137. https:\/\/doi.org\/10.1111\/jcpe.13063.","journal-title":"J Clin Periodontol"},{"key":"2814_CR22","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1038\/s41598-022-06473-4","volume":"12","author":"SAM Siawasch","year":"2022","unstructured":"Siawasch SAM, Andrade C, Castro AB, et al. Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study. Sci Rep. 2022;12:2710. https:\/\/doi.org\/10.1038\/s41598-022-06473-4.","journal-title":"Sci Rep"},{"key":"2814_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"AW Bauer","year":"1966","unstructured":"Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493\u20136.","journal-title":"Am J Clin Pathol"},{"key":"2814_CR24","first-page":"112","volume":"11","author":"MP Weinstein","year":"2018","unstructured":"Weinstein MP, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clin Lab Stand Inst. 2018;11:112.","journal-title":"Clin Lab Stand Inst"},{"key":"2814_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2018.01.012","author":"L Fortunato","year":"2018","unstructured":"Fortunato L, Barone S, Bennardo F, Giudice A. Management of facial pyoderma gangrenosum using platelet-rich fibrin: a technical report. J Oral Maxillofac Surg. 2018. https:\/\/doi.org\/10.1016\/j.joms.2018.01.012.","journal-title":"J Oral Maxillofac Surg"},{"key":"2814_CR26","unstructured":"Giudice A, Esposito M, Bennardo F, et al (2019) Dental extractions for patients on oral antiplatelet: a within-person randomised controlled trial comparing haemostatic plugs, advanced-plateletrich fibrin (A-PRF+) plugs, leukocyte- and plateletrich fibrin (L-PRF) plugs and suturing alone. Eur J Oral Implantol 12"},{"key":"2814_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2020.01.014","author":"L Fortunato","year":"2020","unstructured":"Fortunato L, Bennardo F, Buffone C, Giudice A. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review. J Cranio-Maxillofacial Surg. 2020. https:\/\/doi.org\/10.1016\/j.jcms.2020.01.014.","journal-title":"J Cranio-Maxillofacial Surg"},{"key":"2814_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13334","author":"F Bennardo","year":"2020","unstructured":"Bennardo F, Bennardo L, Del Duca E, et al. Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw. Dermatol Ther. 2020. https:\/\/doi.org\/10.1111\/dth.13334.","journal-title":"Dermatol Ther"},{"key":"2814_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00784-019-03003-x","volume":"24","author":"NB Karan","year":"2020","unstructured":"Karan NB, Aricio\u011flu B. Assessment of bone healing after mineral trioxide aggregate and platelet-rich fibrin application in periapical lesions using cone-beam computed tomographic imaging. Clin Oral Investig. 2020;24:1065\u201372. https:\/\/doi.org\/10.1007\/s00784-019-03003-x.","journal-title":"Clin Oral Investig"},{"key":"2814_CR30","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00784-021-03825-8","volume":"25","author":"RJ Miron","year":"2021","unstructured":"Miron RJ, Moraschini V, Fujioka-Kobayashi M, et al. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis. Clin Oral Investig. 2021;25:2461\u201378. https:\/\/doi.org\/10.1007\/s00784-021-03825-8.","journal-title":"Clin Oral Investig"},{"key":"2814_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-020-03420-3","author":"Y Brancaccio","year":"2020","unstructured":"Brancaccio Y, Antonelli A, Barone S, et al. Evaluation of local hemostatic efficacy after dental extractions in patients taking antiplatelet drugs: a randomized clinical trial. Clin Oral Investig. 2020. https:\/\/doi.org\/10.1007\/s00784-020-03420-3.","journal-title":"Clin Oral Investig"},{"key":"2814_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.actbio.2018.05.021","volume":"75","author":"RJ Miron","year":"2018","unstructured":"Miron RJ, Zhang Y. Autologous liquid platelet rich fibrin: a novel drug delivery system. Acta Biomater. 2018;75:35\u201351. https:\/\/doi.org\/10.1016\/j.actbio.2018.05.021.","journal-title":"Acta Biomater"},{"key":"2814_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.blo.0000143554.56897.26","volume":"427","author":"AC McLaren","year":"2004","unstructured":"McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004;427:101\u20136. https:\/\/doi.org\/10.1097\/01.blo.0000143554.56897.26.","journal-title":"Clin Orthop Relat Res"},{"key":"2814_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.orthres.2004.03.003","volume":"23","author":"CM Stevens","year":"2005","unstructured":"Stevens CM, Tetsworth KD, Calhoun JH, Mader JT. An articulated antibiotic spacer used for infected total knee arthroplasty: a comparative in vitro elution study of Simplex\u00ae and Palacos\u00ae bone cements. J Orthop Res. 2005;23:27\u201333. https:\/\/doi.org\/10.1016\/j.orthres.2004.03.003.","journal-title":"J Orthop Res"},{"key":"2814_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/BLO.0b013e31811ff866","volume":"462","author":"V Antoci","year":"2007","unstructured":"Antoci V, Adams CS, Hickok NJ, et al. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res. 2007;462:200\u20136. https:\/\/doi.org\/10.1097\/BLO.0b013e31811ff866.","journal-title":"Clin Orthop Relat Res"},{"key":"2814_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/ten.tea.2017.0319","volume":"24","author":"J Gessmann","year":"2018","unstructured":"Gessmann J, Seybold D, Ayami F, et al. Peripheral blood plasma clot as a local antimicrobial drug delivery matrix. Tissue Eng A. 2018;24:809\u201318. https:\/\/doi.org\/10.1089\/ten.tea.2017.0319.","journal-title":"Tissue Eng A"},{"key":"2814_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1128\/AAC.00729-05","volume":"51","author":"N Duewelhenke","year":"2007","unstructured":"Duewelhenke N, Krut O, Eysel P. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother. 2007;51:54\u201363. https:\/\/doi.org\/10.1128\/AAC.00729-05.","journal-title":"Antimicrob Agents Chemother"},{"key":"2814_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02120767","volume":"161","author":"AB Fischer","year":"1975","unstructured":"Fischer AB. Gentamicin as a bactericidal antibiotic in tissue culture. Med Microbiol Immunol. 1975;161:23\u201339. https:\/\/doi.org\/10.1007\/BF02120767.","journal-title":"Med Microbiol Immunol"},{"key":"2814_CR39","doi-asserted-by":"crossref","unstructured":"Edin ML, Miclau T, Lester GE, et al (1996) Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 245\u201351","DOI":"10.1097\/00003086-199612000-00027"},{"key":"2814_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1759792","author":"S Wang","year":"2020","unstructured":"Wang S, Li Y, Li S, et al. Platelet-rich plasma loaded with antibiotics as an affiliated treatment for infected bone defect by combining wound healing property and antibacterial activity. Platelets. 2020. https:\/\/doi.org\/10.1080\/09537104.2020.1759792.","journal-title":"Platelets"},{"key":"2814_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-022-04510-0","author":"E Ercan","year":"2022","unstructured":"Ercan E, Suner SS, Silan C, et al. Titanium platelet\u2013rich fibrin (T-PRF) as high-capacity doxycycline delivery system. Clin Oral Investig. 2022. https:\/\/doi.org\/10.1007\/s00784-022-04510-0.","journal-title":"Clin Oral Investig"},{"key":"2814_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1537-2995.1989.29189101158.x","volume":"29","author":"L Williams","year":"1989","unstructured":"Williams L, Domen R. Vancomycin-induced red cell aggregation. Transfusion. 1989;29:23\u20136. https:\/\/doi.org\/10.1046\/j.1537-2995.1989.29189101158.x.","journal-title":"Transfusion"},{"key":"2814_CR43","doi-asserted-by":"publisher","first-page":"e0181090","DOI":"10.1371\/journal.pone.0181090","volume":"12","author":"D Knafl","year":"2017","unstructured":"Knafl D, Thalhammer F, Vossen MG. In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin\u2014layer (PRF)\u2014a laboratory evaluation of a modern, autologous wound treatment. PLoS ONE. 2017;12:e0181090. https:\/\/doi.org\/10.1371\/journal.pone.0181090.","journal-title":"PLoS ONE"},{"key":"2814_CR44","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00784-019-03022-8","volume":"24","author":"AS Mamajiwala","year":"2020","unstructured":"Mamajiwala AS, Sethi KS, Raut CP, et al. Impact of different platelet-rich fibrin (PRF) procurement methods on the platelet count, antimicrobial efficacy, and fibrin network pattern in different age groups: an in vitro study. Clin Oral Investig. 2020;24:1663\u201375. https:\/\/doi.org\/10.1007\/s00784-019-03022-8.","journal-title":"Clin Oral Investig"},{"key":"2814_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1563\/aaid-joi-D-14-00138","volume":"40","author":"S Ghanaati","year":"2014","unstructured":"Ghanaati S, Booms P, Orlowska A, et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014;40:679\u201389. https:\/\/doi.org\/10.1563\/aaid-joi-D-14-00138.","journal-title":"J Oral Implantol"},{"key":"2814_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/09537104.2018.1445835","volume":"30","author":"A Kubesch","year":"2019","unstructured":"Kubesch A, Barbeck M, Al-Maawi S, et al. A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: an experimental study in vivo. Platelets. 2019;30:329\u201340. https:\/\/doi.org\/10.1080\/09537104.2018.1445835.","journal-title":"Platelets"},{"key":"2814_CR47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00784-019-02981-2","volume":"24","author":"RJ Miron","year":"2020","unstructured":"Miron RJ, Xu H, Chai J, et al. Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces. Clin Oral Investig. 2020;24:1171\u201382. https:\/\/doi.org\/10.1007\/s00784-019-02981-2.","journal-title":"Clin Oral Investig"},{"key":"2814_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/09537104.2020.1754382","volume":"32","author":"M Fujioka-Kobayashi","year":"2021","unstructured":"Fujioka-Kobayashi M, Kono M, Katagiri H, et al. Histological comparison of Platelet rich fibrin clots prepared by fixed-angle versus horizontal centrifugation. Platelets. 2021;32:413\u20139. https:\/\/doi.org\/10.1080\/09537104.2020.1754382.","journal-title":"Platelets"},{"key":"2814_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-020-00099-w","volume":"12","author":"M Feng","year":"2020","unstructured":"Feng M, Wang Y, Zhang P, et al. Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation. Int J Oral Sci. 2020;12:32. https:\/\/doi.org\/10.1038\/s41368-020-00099-w.","journal-title":"Int J Oral Sci"},{"key":"2814_CR50","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00784-021-04268-x","volume":"26","author":"RJ Miron","year":"2022","unstructured":"Miron RJ, Horrocks NA, Zhang Y, et al. Extending the working properties of liquid platelet-rich fibrin using chemically modified PET tubes and the Bio-Cool device. Clin Oral Investig. 2022;26:2873\u20138. https:\/\/doi.org\/10.1007\/s00784-021-04268-x.","journal-title":"Clin Oral Investig"},{"key":"2814_CR51","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00784-018-2673-x","volume":"23","author":"RJ Miron","year":"2019","unstructured":"Miron RJ, Dham A, Dham U, et al. The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes. Clin Oral Investig. 2019;23:2179\u201385. https:\/\/doi.org\/10.1007\/s00784-018-2673-x.","journal-title":"Clin Oral Investig"},{"key":"2814_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-022-04496-9","author":"Y Wei","year":"2022","unstructured":"Wei Y, Cheng Y, Wang Y, et al. The effect of resting and compression time post-centrifugation on the characteristics of platelet rich fibrin (PRF) membranes. Clin Oral Investig. 2022. https:\/\/doi.org\/10.1007\/s00784-022-04496-9.","journal-title":"Clin Oral Investig"},{"key":"2814_CR53","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/09537104.2015.1116686","volume":"27","author":"FM Del","year":"2016","unstructured":"Del FM, Bortolin M, Taschieri S, et al. Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets. 2016;27:276\u201385. https:\/\/doi.org\/10.3109\/09537104.2015.1116686.","journal-title":"Platelets"},{"key":"2814_CR54","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/cid\/ciu395","volume":"59","author":"AN Schuetz","year":"2014","unstructured":"Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis. 2014;59:698\u2013705. https:\/\/doi.org\/10.1093\/cid\/ciu395.","journal-title":"Clin Infect Dis"},{"key":"2814_CR55","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1007\/s00784-021-03929-1","volume":"25","author":"MT Elbehwashy","year":"2021","unstructured":"Elbehwashy MT, Hosny MM, Elfana A, et al. Clinical and radiographic effects of ascorbic acid-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial. Clin Oral Investig. 2021;25:6309\u201319. https:\/\/doi.org\/10.1007\/s00784-021-03929-1.","journal-title":"Clin Oral Investig"},{"key":"2814_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2022.03.006","author":"R Asher","year":"2022","unstructured":"Asher R, Oren F, Meir T, et al. Tranexamic acid integrated into platelet-rich fibrin produces a robust and resilient antihemorrhagic biological agent: a human cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022. https:\/\/doi.org\/10.1016\/j.oooo.2022.03.006.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2814_CR57","first-page":"651","volume":"66","author":"S Mohsen","year":"2020","unstructured":"Mohsen S, Dickinson JA, Somayaji R. Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician. 2020;66:651\u20139.","journal-title":"Can Fam Physician"},{"key":"2814_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","volume":"78","author":"BD Brooks","year":"2014","unstructured":"Brooks BD, Brooks AE. Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev. 2014;78:14\u201327. https:\/\/doi.org\/10.1016\/j.addr.2014.10.027.","journal-title":"Adv Drug Deliv Rev"},{"key":"2814_CR59","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jac\/38.5.829","volume":"38","author":"YW Miller","year":"1996","unstructured":"Miller YW, Eady EA, Lacey RW, et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother. 1996;38:829\u201337. https:\/\/doi.org\/10.1093\/jac\/38.5.829.","journal-title":"J Antimicrob Chemother"},{"key":"2814_CR60","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bjo.2005.068981","volume":"89","author":"BD Gaynor","year":"2005","unstructured":"Gaynor BD. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005;89:1097\u20139. https:\/\/doi.org\/10.1136\/bjo.2005.068981.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-02814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-02814-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-02814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:03:34Z","timestamp":1678320214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-02814-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2814"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-02814-5","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the Declaration of Helsinki on medical protocol and ethics, the regional Ethical Review Board of Central Calabria (reference for the Magna Graecia University of Catanzaro) approved blood collecting for experiments related to PRF (Prot. No. 23\u201317.01.19). The approval for the overall study protocol was received from the IRB of the School of Dentistry of the Magna Graecia University of Catanzaro. The study was performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}